Assertio Therapeutics, Inc. (ASRT): Price and Financial Metrics

Assertio Therapeutics, Inc. (ASRT): $1.15

0.01 (-0.86%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add ASRT to Watchlist
Sign Up

ASRT Price/Volume Stats

Current price $1.15 52-week high $6.30
Prev. close $1.16 52-week low $0.73
Day low $1.13 Volume 1,784,700
Day high $1.25 Avg. volume 945,513
50-day MA $0.98 Dividend yield N/A
200-day MA $1.33 Market Cap 109.39M

ASRT Stock Price Chart Interactive Chart >


Assertio Therapeutics, Inc. (ASRT) Company Bio


Assertio Therapeutics, Inc. (formerly DepoMed) develops products for pain and other central nervous system conditions in the United States. The company was founded in 1995 and is focused in Newark, California.


ASRT Latest News Stream


Event/Time News Detail
Loading, please wait...

ASRT Latest Social Stream


Loading social stream, please wait...

View Full ASRT Social Stream

Latest ASRT News From Around the Web

Below are the latest news stories about ASSERTIO HOLDINGS INC that investors may wish to consider to help them evaluate ASRT as an investment opportunity.

Pre-Surge Penny Picks: 3 Stocks to Buy Before They Boom

Investing in penny stocks can be a great way to unlock gains from your portfolio.

Matthew Farley on InvestorPlace | December 25, 2023

With 51% ownership of the shares, Assertio Holdings, Inc. (NASDAQ:ASRT) is heavily dominated by institutional owners

Key Insights Institutions' substantial holdings in Assertio Holdings implies that they have significant influence over...

Yahoo | November 17, 2023

Assertio Holdings, Inc. Appoints Sravan Emany to Its Board of Directors

LAKE FOREST, Ill., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company that acquires, commercializes and develops safe and effective therapies that make a difference in the lives of patients, announced today that Sravan Emany has been appointed to the Company’s Board of Directors. As part of the appointment, Assertio has expanded its board to seven seats. Mr. Emany currently serves as the Chief Financial Offic

Yahoo | November 14, 2023

Assertio Holdings, Inc. (NASDAQ:ASRT) Q3 2023 Earnings Call Transcript

Assertio Holdings, Inc. (NASDAQ:ASRT) Q3 2023 Earnings Call Transcript November 8, 2023 Assertio Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.46 EPS, expectations were $0.23. Operator: Good morning and welcome to the Assertio Holdings Inc. Third Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode. After today’s presentation, there […]

Yahoo | November 10, 2023

Astra Space (ASTR) Stock Spikes 82% on Take-Private Proposal

Astra Space stock is taking off on Thursday as investors react to a take-private offer for ASTR shares from the company's founders.

William White on InvestorPlace | November 9, 2023

Read More 'ASRT' Stories Here

ASRT Price Returns

1-mo 15.00%
3-mo 10.58%
6-mo 0.00%
1-year -79.90%
3-year -30.30%
5-year -90.96%
YTD 7.48%
2023 -75.12%
2022 97.25%
2021 52.40%
2020 -71.39%
2019 -65.37%

Continue Researching ASRT

Here are a few links from around the web to help you further your research on Assertio Therapeutics Inc's stock as an investment opportunity:

Assertio Therapeutics Inc (ASRT) Stock Price | Nasdaq
Assertio Therapeutics Inc (ASRT) Stock Quote, History and News - Yahoo Finance
Assertio Therapeutics Inc (ASRT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!